If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
14
Followers on Owler
Overview
Competitors
Funding
Investments
News & Insights
Cassel Salpeter Investments
Cassel Salpeter has invested in 1 company and its latest investment was Inhibrx on May 03, 2018
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
Follow
InhibRx is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$3.5M
May 03, 2018
-
